Aaron Pearce
Analyst · Wells Fargo. Your line is open
Thank you, Michael. Good morning, everyone, and thank you for joining us this morning. I'll start the financial review on Slide 3. Sales in the second quarter were $318.1 million, which was an increase of 19.6% when compared to the same quarter last year. And GAAP pre-tax earnings increased 6.7% to $42 million. Impacting earnings this quarter was a significant increase in amortization expense from the acquisitions completed at the end of last year. If you exclude amortization expense from all periods presented, then our pre-tax earnings would have increased by 12.4% to $45.8 million. GAAP diluted EPS was $0.65, which was an increase of 10.2% over last year's second quarter. And if you exclude amortization expense, then EPS would have increased by 14.8% to $0.70 this quarter compared to $0.61 in the second quarter of last year. So financially, Q2 was another very strong quarter despite the logistical challenges and the inflationary pressures that Michael just mentioned. Moving to Slide 4, you'll find our quarterly sales trends. Our nearly 20% sales increase consisted of organic growth of 13.1% and an increase from acquisitions of 8.6%. This was then partially offset by a decline of 2.1% from foreign currency translation. Organic sales grew in each of our two divisions. ID Solutions had robust organic sales growth of 16% and Workplace Safety Return to growth clocking organic growth of 5.2% this quarter. Turning to Slide 5, for our gross profit margin trending, our margin was 47% this quarter compared to 48.7% in the second quarter of last year. As Michael mentioned, we're experiencing inflationary pressures in nearly all cost categories, but we're automating across our sites, we're driving efficiencies throughout the entire organization and we're putting through selective price increases to offset these cost increases. On Slide 6, you'll find our SG&A expense trending. When comparing to last year's Q2 SG&A of $82.2 million, this year's SG&A of $92.5 million, there are two main items impacting comparability. First, the amortization expense from the three acquisitions completed at the end of fiscal '21 added $2.4 million of expense. And second, the remaining SG&A expense from these three acquisitions added another $5.3 million. Excluding these acquisitions, SG&A was up approximately 3% in Q2 versus the same quarter of last year. And as a percent of sales, SG&A was 29.1% this quarter compared to 30.9% in the second quarter of last year, which illustrates how we're able to continue to squeeze leverage out of our SG&A structure. Plus, if you exclude amortization from both the current year and the prior year, then SG&A would have declined even more declining from 30.4% of sales last year to 27.9% of sales this year. We continue to make progress in driving down SG&A as a percent of sales and believe that we still have numerous opportunities ahead of us. Slide 7 is the trending of our investments in research and development. This quarter, we invested $14 million in R&D, which equates to about 4.4% of sales. We're committed to maintaining this increased level of R&D investment as we continue to see opportunities for R&D across our businesses, including building out a comprehensive industrial track and trace platform that encompasses our printers, high quality materials, RFID scanners, and barcode scanners. These investments in R&D are critical to sustaining our increased growth rate over the long term. Slide 8 illustrates our pre-tax income trends. Pre-tax earnings increased 6.7% on a GAAP basis and increased 12.4% if you exclude amortization expense from all periods. Slide 9 illustrates our after-tax income and EPS trends, as I mentioned, our GAAP EPS increased 10.2% this quarter and if you exclude the after-tax impact of amortization expense, our EPS would have increased by an even stronger 14.8%. Last year was a record EPS year for Brady and even with last year's tough comparables, year-to-date our EPS excluding amortization is a full 12.6% ahead of last year at this time. On Slide 10, you'll find a summary of our cash generation. This quarter we intentionally increased our inventory levels to ensure that we have the materials available to meet the future needs of our customers. This quarter we had a cash outflow of $17.8 million related to our building of inventory levels. Although, we're still working to secure a larger supply of certain critical products, we don't anticipate the ramp up in our inventory levels to continue at this pace other than to support the increase in sales levels. We also paid out our fiscal 2021 incentive-based compensation this quarter, which had a negative impact on our cash generation. As a result of these two significant cash outflows, we finished with cash flow from operating activities of negative $3.2 million this quarter. As we move in to the back half of this fiscal year, we expect our cash flow to improve significantly as our intentional building of inventory subsides. Now if you'll turn to Slide 11, you can see the impact that Brady's historically strong cash generation has had on our balance sheet. Even after returning funds to our shareholders and building up inventories to ensure that we're poised to meet future customer demand, on January 31, we were still in a net cash position of more than $64 million. Our strong balance sheet puts us in a fantastic position to execute additional value enhancing activities including investing in R&D, completing additional acquisitions and returning funds to our shareholders. Our approach to capital allocation is to first use our cash to fully fund organic sales and efficiency opportunities throughout the economic cycle. This includes investing in new product development, sales generating resources, IT improvements, capability enhancing CapEx and automation focused capital expenditures. We will absolutely keep funding these investments where it makes sense and where the investments are ROI positive. And second, we focus on returning cash to our shareholders in the form of dividends. We've now increased our annual dividend for 36 consecutive years. After fully funding organic investments and dividends, we then deploy our cash in a disciplined manner for either acquisitions where we have strong synergistic opportunities or for buybacks when we see a disconnect in our view of intrinsic value versus Brady's trading price. This quarter we returned $14.5 million to our shareholders in the form of dividends and share buybacks. And in the first half of this year, we returned a total of $45 million to our shareholders, which illustrates our commitment to return capital to our shareholders. Subsequent to our quarter-end on January 31st, we repurchased another $9 million worth of shares bringing our total share buybacks from August 1, 2021, through today to $30.7 million, which was just over 612,000 shares. As we look to the back half of this year and assuming current market conditions persist, we expect to continue using our share buybacks as a tool to return funds to our shareholders. Slide 12 summarizes our updated guidance for the year ending July 31, 2022. Although organic sales growth was strong, our gross profit margin during the six months ended January 31, 2022, was a bit weaker than we had originally anticipated as cost have increased faster than expected. We expected these cost pressures to continue to impact our gross profit margin for at least the short-term before price increases and efficiency actions are able to offset these inflationary forces. In the second half of fiscal 2022, we expect our gross profit margins to improve from the 47% realized last quarter, but we don't expect our margins to fully return to pre-pandemic levels. As such, we're adjusting our diluted EPS excluding amortization guidance from our original range of $3.12 to $3.32 per share to our new range of $3 to $3.15 per share. This equates to a revised GAAP EPS guidance range of $2.78 to $2.93 per share. This revised guidance range implies that we expect fiscal 2022 GAAP earnings per diluted share to increase from 13% to 19% when compared to our previous record EPS here in fiscal 2021. And if you exclude amortization and the non-recurring charges incurred last year, we expect EPS to improve by 9% to 15% for the full year ending July 31, 2022. Included in our GAAP earnings per share guidance is an increase in after-tax amortization expense of approximately $6 million. After-tax amortization increased from about $5.5 million in fiscal 2021 to about $11.5 million in fiscal 2022, which is a delta of approximately $0.12 per share. The other elements of our guidance are pretty much in line with what we shared last quarter. Specifically, we expect the full year income tax rate of approximately 20% and depreciation and amortization expense to range from $34 million to $36 million. Capital expenditures excluding any future facility purchases are expected to range from $27 million to $32 million. This CapEx guidance range of $27 million to $32 million is inclusive of the $8 million of facility purchases we already incurred in the first half of this year. This guidance is based on foreign currency exchange rates as of January 31, 2022, and assumes continued economic growth. As we look forward to the rest of this fiscal year, we will continue to make the investments necessary to drive organic sales growth. We'll continue to search for acquisitions that advance our strategies and we'll continue to drive sustainable efficiency gains while being tight on non-revenue generating expenses. As for capital allocation, we'll keep investing in our organic business. We will keep investing in our industrial track and trace initiatives. We will continue to return funds to our shareholders through dividends and through buybacks if the price is right. And lastly, we will continue to look for acquisitions where the strategic fit is clear. We have a strong balance sheet and we use it as a tool to drive long-term shareholder value. Potential risks to this guidance among others include the strengthening of the U.S. dollar versus other major currencies such as the Euro or the Pound, worsening logistics that don't allow us to meet our commitments to our customers, further lockdowns or increased inflationary pressures that we can't offset in a timely enough manner. I'll now turn the call back to Michael to cover our divisional results and to provide some closing comments before the Q&A session. Michael?